AAAAAA

   
Results: 1-8 |
Results: 8
THYMIDINE PHOSPHORYLASE MODERATES THYMIDINE-DEPENDENT RESCUE AFTER EXPOSURE TO THE THYMIDYLATE SYNTHASE INHIBITOR ZD1694 (TOMUDEX) IN-VITRO
Authors: PATTERSON AV TALBOT DC STRATFORD IJ HARRIS AL
Citation: Av. Patterson et al., THYMIDINE PHOSPHORYLASE MODERATES THYMIDINE-DEPENDENT RESCUE AFTER EXPOSURE TO THE THYMIDYLATE SYNTHASE INHIBITOR ZD1694 (TOMUDEX) IN-VITRO, Cancer research, 58(13), 1998, pp. 2737-2740
USING GENE-THERAPY TO DETERMINE THE MECHANISM OF HYPOXIC ACTIVATION OF TIRAPAZAMINE
Authors: CHINJE EC SAUNDERS MP FRANKLIN G ROBERTSON N PATTERSON AV STRATFORD IJ
Citation: Ec. Chinje et al., USING GENE-THERAPY TO DETERMINE THE MECHANISM OF HYPOXIC ACTIVATION OF TIRAPAZAMINE, British Journal of Cancer, 78, 1998, pp. 27-27
SELECTIVELY ACTIVATING BIOREDUCTIVE DRUGS IN-VITRO USING GENE-THERAPY
Authors: SAUNDERS MP PATTERSON AV RATCLIFFE PJ HARRIS AL STRATFORD IJ
Citation: Mp. Saunders et al., SELECTIVELY ACTIVATING BIOREDUCTIVE DRUGS IN-VITRO USING GENE-THERAPY, British Journal of Cancer, 78, 1998, pp. 47-47
TARGETING GENE-EXPRESSION TO HYPOXIC TUMOR-CELLS
Authors: DACHS GU PATTERSON AV FIRTH JD RATCLIFFE PJ TOWNSEND KMS STRATFORD IJ HARRIS AL
Citation: Gu. Dachs et al., TARGETING GENE-EXPRESSION TO HYPOXIC TUMOR-CELLS, Nature medicine, 3(5), 1997, pp. 515-520
OVEREXPRESSION OF HUMAN NADPH-CYTOCHROME-C (P450) REDUCTASE CONFERS ENHANCED SENSITIVITY TO BOTH TIRAPAZAMINE (SR 4233) AND RSU 1069
Authors: PATTERSON AV SAUNDERS MP CHINJE EC TALBOT DC HARRIS AL STRATFORD IJ
Citation: Av. Patterson et al., OVEREXPRESSION OF HUMAN NADPH-CYTOCHROME-C (P450) REDUCTASE CONFERS ENHANCED SENSITIVITY TO BOTH TIRAPAZAMINE (SR 4233) AND RSU 1069, British Journal of Cancer, 76(10), 1997, pp. 1338-1347
IMPORTANCE OF P450 REDUCTASE-ACTIVITY IN DETERMINING SENSITIVITY OF BREAST-TUMOR CELLS TO THE BIOREDUCTIVE DRUG, TIRAPAZAMINE (SR-4233)
Authors: PATTERSON AV BARHAM HM CHINJE EC ADAMS GE HARRIS AL STRATFORD IJ
Citation: Av. Patterson et al., IMPORTANCE OF P450 REDUCTASE-ACTIVITY IN DETERMINING SENSITIVITY OF BREAST-TUMOR CELLS TO THE BIOREDUCTIVE DRUG, TIRAPAZAMINE (SR-4233), British Journal of Cancer, 72(5), 1995, pp. 1144-1150
INCREASED SENSITIVITY TO THE PRODRUG 5'-DEOXY-5-FLUOROURIDINE AND MODULATION OF 5-FLUORO-2'-DEOXYURIDINE SENSITIVITY IN MCF-7 CELLS TRANSFECTED WITH THYMIDINE PHOSPHORYLASE
Authors: PATTERSON AV ZHANG H MOGHADDAM A BICKNELL R TALBOT DC STRATFORD IJ HARRIS AL
Citation: Av. Patterson et al., INCREASED SENSITIVITY TO THE PRODRUG 5'-DEOXY-5-FLUOROURIDINE AND MODULATION OF 5-FLUORO-2'-DEOXYURIDINE SENSITIVITY IN MCF-7 CELLS TRANSFECTED WITH THYMIDINE PHOSPHORYLASE, British Journal of Cancer, 72(3), 1995, pp. 669-675
THE ROLE OF DT-DIAPHORASE IN DETERMINING THE SENSITIVITY OF HUMAN TUMOR-CELLS TO TIRAPAZAMINE (SR-4233)
Authors: PATTERSON AV ROBERTSON N HOULBROOK S STEPHENS MA ADAMS GE HARRIS AL STRATFORD IJ CARMICHAEL J
Citation: Av. Patterson et al., THE ROLE OF DT-DIAPHORASE IN DETERMINING THE SENSITIVITY OF HUMAN TUMOR-CELLS TO TIRAPAZAMINE (SR-4233), International journal of radiation oncology, biology, physics, 29(2), 1994, pp. 369-372
Risultati: 1-8 |